Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -0.66% | -6.25% | +273.13% |
Financials (USD)
Sales 2024 * | 523K | Sales 2025 * | 321K | Capitalization | 1.01B |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -64M | EV / Sales 2024 * | 1,932 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3,145 x |
P/E ratio 2024 * |
-15.3
x | P/E ratio 2025 * |
-13.8
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.58% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | -0.66% | ||
1 week | -6.25% | ||
Current month | -10.71% | ||
1 month | -5.06% | ||
3 months | +66.67% | ||
6 months | +488.70% | ||
Current year | +273.13% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 52 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | 17-06-30 |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 61 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.5 | -0.66% | 6,754,108 |
24-05-23 | 1.51 | +1.34% | 3,794,285 |
24-05-22 | 1.49 | -6.29% | 3,054,640 |
24-05-21 | 1.59 | -2.45% | 4,056,587 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+273.13% | 1.01B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CATX Stock